News Albert Labs International Corp. OTC Markets

Equities

ALBLF

CA0127841041

Market Closed - OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2023	Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors	18/10/23	CI
Albert Labs International Corp. Announces Resignation of Michael Raymont as Board of Directors	05/09/23	CI
Albert Labs International Corp. Announces CEO Changes	05/09/23	CI
Albert Labs International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23	CI
CSE Bulletin: Reinstatement - Albert Labs International Corp. (ABRT)	07/07/23	NE
Canadian Investment Regulatory Organization Trade Resumption - ABRT	07/07/23	AQ
Albert Labs International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	07/06/23	CI
Albert Labs International Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	02/06/23	CI
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	01/06/23	CI
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI	09/05/23	NE
IIROC Trading Halt - ABRT	09/05/23	AQ
Albert Labs International Corp. Announces Preliminary Acceptance of 35 Novel Innovative Claims	02/05/23	CI
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology	02/05/23	AQ
Albert Labs announces Private Placement	24/04/23	AQ
Albert Labs International Corp. announced that it expects to receive CAD 3 million in funding	23/04/23	CI
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials	28/03/23	AQ
Albert Labs International Corp. announced that it expects to receive CAD 0.83 million in funding from Cantheon Capital	22/03/23	CI
Albert Labs Validates Global Supply Chain for Controlled Substances	15/03/23	AQ
Albert Labs International Corp. announced that it has received CAD 0.3 million in funding	23/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Albert Labs International Corp. OTC Markets

Equities

ALBLF

CA0127841041

Summary

Filters